The glucagon-like peptide-1 receptor agonist (GLP-1RA) and dipeptidyl peptidase-IV (DPP-IV) inhibitor are very often used in subjects with type 2 diabetes mellitus (T2DM). The gene discussed is DPP4; the disease is diabetes mellitus.